🇺🇸 FDA
Patent

US 6936639

Nitroxyl progenitors in the treatment of heart failure

expired A61KA61K31/13A61K31/16

Quick answer

US patent 6936639 (Nitroxyl progenitors in the treatment of heart failure) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/13, A61K31/16, A61K31/655, A61K33/00